AbCellera
-
Beyond COVID-19: How mRNA technology could transform how we treat disease
Dr. Anna Blakney, assistant professor at UBC’s Michael Smith Laboratories and school of biomedical engineering, describes how mRNA technology could transform how we treat disease.
-
UBC-grown biotech companies lead global pandemic efforts
Millions of Canadians have received the Pfizer-BioNTech COVID-19 vaccine, but what many may not realize is that a key component of the injection was developed right here at UBC.
-
UBC researchers play pivotal role in confronting COVID-19
The COVID-19 pandemic has highlighted challenges, exacerbated inequalities and sparked uncertainty for many. But one area of particular strength and inspiration is Canada’s research community and its response to the pandemic.